Loading data
PRAXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 8.55 m USD | 2.45 m USD | 0 USD | — |
| Research and development expense | 267.12 m USD | 152.41 m USD | 86.77 m USD | 155.04 m USD | 120.26 m USD |
| Operating profit | -326.2 m USD | -200.17 m USD | -126.37 m USD | -214.99 m USD | -167.33 m USD |
| Profit before tax | -302.8 m USD | -182.74 m USD | -123.01 m USD | — | — |
| Income tax expense | 471 k USD | — | — | — | — |
| Net income (reported basis) | -303 m USD | -183 m USD | -123 m USD | -214 m USD | -167 m USD |
| Basic earnings per share | -13.48 USD/share | -10.21 USD/share | -18.69 USD/share | -69.65 USD/share | -3.94 USD/share |
| Diluted earnings per share | -13.48 USD/share | -10.21 USD/share | -18.69 USD/share | -69.65 USD/share | -3.94 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.